CJC1295 DAC
What is CJC1295 DAC?
CJC1295 DAC is a synthetic peptide and growth hormone-releasing hormone (GHRH) analog, designed to stimulate the release of growth hormone (GH) over an extended period. The DAC (Drug Affinity Complex) component extends its half-life, making it effective for sustained GH release.
How It Works (Mechanism of Action)
CJC1295 DAC binds to GHRH receptors in the pituitary gland, promoting the secretion of growth hormone. This leads to increased levels of insulin-like growth factor 1 (IGF-1), which supports muscle growth, fat metabolism, and tissue repair.
Potential Benefits & Use Cases
- Muscle Growth: Enhances muscle mass and strength through increased GH levels.
- Fat Loss: Promotes lipolysis and fat metabolism.
- Recovery: Improves recovery from exercise and injuries.
- Anti-Aging: May support overall vitality and energy levels.
Typical Dosage & Administration
Administration: Subcutaneous injection.
Dosage:
- Typical doses range from 1 mg to 2 mg per week.
- Often administered in 1-2 injections per week due to its long half-life.
Possible Side Effects
- Injection Site Reactions: Redness or irritation at the injection site.
- Headaches: Some users report mild headaches.
- Water Retention: Possible mild bloating due to increased GH levels.
Other Relevant Details
- Often stacked with Ipamorelin for synergistic effects on GH release.
- Under investigation for long-term effects on growth hormone regulation.